Breaking News
Get 40% Off 0
👀 👁 🧿 All eyes on Biogen, up +4,56% after posting earnings. Our AI picked it in March 2024.
Which stocks will surge next?
Unlock AI-picked Stocks
Close

Panbela Therapeutics Inc (PBLA)

Create Alert
New!
Create Alert
Website
  • As an alert notification
  • To use this feature, make sure you are signed-in to your account
Mobile App
  • To use this feature, make sure you are signed-in to your account
  • Make sure you are signed-in with the same user profile

Condition

Frequency

Once
%

Frequency

Frequency

Delivery Method

Status

Add to/Remove from Watchlist Add to Watchlist
Add to Watchlist
Add Position

Position added successfully to:

Please name your holdings portfolio
 
0.410 -0.030    -6.82%
26/04 - Closed. Currency in USD ( Disclaimer )
Type:  Equity
Market:  United States
  • Volume: 48,218
  • Bid/Ask: 0.000 / 0.000
  • Day's Range: 0.350 - 0.430
Panbela Therapeutics 0.410 -0.030 -6.82%

Panbela Therapeutics Inc Company Profile

 
Get an in-depth profile of Panbela Therapeutics Inc, including a general overview of the company's business and key management, as well as employee data and location and contact information.
IndustryBiotechnology & Medical Research
SectorHealthcare
Employees

8

Equity Type

ORD

Panbela Therapeutics, Inc., a clinical-stage biopharmaceutical company, engages in the development of disruptive therapeutics for the treatment of patients with urgent unmet medical needs. The company’s lead product candidates are Ivospemin (SBP-101), a proprietary polyamine analogue, which has completed Phase Ia/Ib clinical trial for the treatment of patients with metastatic pancreatic ductal adenocarcinoma; Flynpovi, a combination of eflornithine (CPP-1X) and sulindac which is in Phase III clinical trials; and Eflornithine, an enzyme-activated irreversible inhibitor of the enzyme ornithine decarboxylase, currently under Phase I/II trial. It has a research agreement with the Johns Hopkins University School of Medicine for the development of ivospemin. The company was formerly known as Sun BioPharma, Inc. and changed its name to Panbela Therapeutics, Inc. in December 2020. Panbela Therapeutics, Inc. was incorporated in 2011 and is based in Waconia, Minnesota.

Contact Information

Address 712 Vista Boulevard Suite 305
Waconia, 55387
United States
Phone 952 479 1196
Fax -

Top Executives

Name Age Since Title
Donald Robert Schemel 68 2015 Independent Director
Arthur J. Fratamico 57 2019 Independent Director
Jennifer K. Simpson 55 2020 CEO, President & Director
Daniel J. Donovan 59 2022 Independent Director
Jeffrey E. Jacob 62 2022 Director
Dusan Kotasek - - Scientific Advisor
Michael T. Cullen 77 2011 Chairman
Jeffrey S. Mathiesen 62 2015 Vice Chair & Lead Independent Director
Andrew H. Ko - - Scientific Advisor
Tanios Bekaii-Saab - - Scientific Advisor
Comment Guidelines

We encourage you to use comments to engage with other users, share your perspective and ask questions of authors and each other. However, in order to maintain the high level of discourse we’ve all come to value and expect, please keep the following criteria in mind:  

  •            Enrich the conversation, don’t trash it.

  •           Stay focused and on track. Only post material that’s relevant to the topic being discussed. 

  •           Be respectful. Even negative opinions can be framed positively and diplomatically. Avoid profanity, slander or personal attacks directed at an author or another user. Racism, sexism and other forms of discrimination will not be tolerated.

  • Use standard writing style. Include punctuation and upper and lower cases. Comments that are written in all caps and contain excessive use of symbols will be removed.
  • NOTE: Spam and/or promotional messages and comments containing links will be removed. Phone numbers, email addresses, links to personal or business websites, Skype/Telegram/WhatsApp etc. addresses (including links to groups) will also be removed; self-promotional material or business-related solicitations or PR (ie, contact me for signals/advice etc.), and/or any other comment that contains personal contact specifcs or advertising will be removed as well. In addition, any of the above-mentioned violations may result in suspension of your account.
  • Doxxing. We do not allow any sharing of private or personal contact or other information about any individual or organization. This will result in immediate suspension of the commentor and his or her account.
  • Don’t monopolize the conversation. We appreciate passion and conviction, but we also strongly believe in giving everyone a chance to air their point of view. Therefore, in addition to civil interaction, we expect commenters to offer their opinions succinctly and thoughtfully, but not so repeatedly that others are annoyed or offended. If we receive complaints about individuals who take over a thread or forum, we reserve the right to ban them from the site, without recourse.
  • Only English comments will be allowed.
  • Any comment you publish, together with your investing.com profile, will be public on investing.com and may be indexed and available through third party search engines, such as Google.

Perpetrators of spam or abuse will be deleted from the site and prohibited from future registration at Investing.com’s discretion.

PBLA Comments

Write your thoughts about Panbela Therapeutics Inc
 
Are you sure you want to delete this chart?
 
Post
Post also to:
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Thanks for your comment. Please note that all comments are pending until approved by our moderators. It may therefore take some time before it appears on our website.
Ayhan Batt
Ayhan Batt Mar 26, 2024 2:45PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
trash
Ayhan Batt
Ayhan Batt Mar 07, 2024 2:06AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
go to otc
Ayhan Batt
Ayhan Batt Jan 22, 2024 10:08PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
sunk this company
Ayhan Batt
Ayhan Batt Jan 19, 2024 6:42AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
very Bad stoks
Ayhan Batu
Ayhan Batu Aug 25, 2023 3:31AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
i think this stocks 100$
Ruben El
Ruben El Aug 25, 2023 3:31AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
almost there
昌 昌
昌 昌 Mar 14, 2023 7:09PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
垃圾公司垃圾票
Jack Belforte
Jack Belforte Mar 03, 2023 7:53AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
PBLA beatdown is a great entry before it moves back to $1.50. The future is on track.
Jack Belforte
Jack Belforte Feb 14, 2023 8:01AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Time to load up on PBLA. Chart move back to $2 and better.
Sean Emerson
Sean Emerson Sep 16, 2022 1:37PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
how in the FKN SHT! ? Does it fluctuate that much and I can't find not one FKN recent sale on it!?
JJ JJ
JJ JJ Aug 03, 2021 4:24PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
 
Are you sure you want to delete this chart?
 
Post
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Add Chart to Comment
Confirm Block

Are you sure you want to block %USER_NAME%?

By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.

%USER_NAME% was successfully added to your Block List

Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.

Report this comment

I feel that this comment is:

Comment flagged

Thank You!

Your report has been sent to our moderators for review
Continue with Google
or
Sign up with Email